Parvovirus B19 infection in human pregnancy
- PMID: 21040396
- PMCID: PMC3059196
- DOI: 10.1111/j.1471-0528.2010.02749.x
Parvovirus B19 infection in human pregnancy
Abstract
Human parvovirus B19 infection is widespread. Approximately 30-50% of pregnant women are nonimmune, and vertical transmission is common following maternal infection in pregnancy. Fetal infection may be associated with a normal outcome, but fetal death may also occur without ultrasound evidence of infectious sequelae. B19 infection should be considered in any case of nonimmune hydrops. Diagnosis is mainly through serology and polymerase chain reaction. Surveillance requires sequential ultrasound and Doppler screening for signs of fetal anaemia, heart failure and hydrops. Immunoglobulins, antiviral and vaccination are not yet available, but intrauterine transfusion in selected cases can be life saving.
© 2010 RCOG No claim to original US government works Journal compilation © RCOG 2010 BJOG An International Journal of Obstetrics and Gynaecology.
Figures


References
-
- From the Centers for Disease Control and Prevention. Rashes among schoolchildren--14 states, October 4, 2001-February 27, 2002 1. JAMA. 2002;287(11):1389–1391. - PubMed
-
- Valeur-Jensen AK, Pedersen CB, Westergaard T, Jensen IP, Lebech M, Andersen PK, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA. 1999;281(12):1099–1105. - PubMed
-
- Dukes C. On the confusion of two different diseases under the name Rubella (rose-rash) Lancet. 1900;156(4011):89–95.
-
- Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet. 1975;1(7898):72–73. - PubMed
-
- Cotmore SF, Tattersall P. Characterization and molecular cloning of a human parvovirus genome. Science. 1984;226(4679):1161–1165. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical